IN'OYA Laboratoire Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $525K
Latest Deal Amount
  • Investors
  • 9

IN'OYA Laboratoire General Information

Description

Developer of cosmetic and skin care products designed for dark and olive skin tones. The company's products focuses on the treatment of hyperpigmentation spots that include serum and moisturizer without side effects, which takes genes into account, enabling women of color to tackle all their skin-related issues.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Internet Retail
Primary Office
  • Pôle d'activités, Y. Morandat 1480
  • Avenue d'Arménie
  • 13120 Gardanne
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IN'OYA Laboratoire Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 07-Jan-2015 $525K 00000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view IN'OYA Laboratoire’s complete valuation and funding history, request access »

IN'OYA Laboratoire Executive Team (2)

Name Title Board Seat Contact Info
Abd Haq Bengeloune Co-Founder & Chief Executive Officer
Laila Mkimer Ph.D Co-Founder & Head of Marketing
To view IN'OYA Laboratoire’s complete executive team members history, request access »

IN'OYA Laboratoire Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bpifrance Sovereign Wealth Fund Minority 000 0000 000000 0
CAAP Creation Venture Capital Minority 000 0000 000000 0
Conseil Plus Gestion Other Minority 000 0000 000000 0
La Banque Populaire de l'Ouest Other Minority 000 0000 000000 0
Pays d'Aix Développement Corporation Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »